相关实验视频

Updated: Jun 23, 2025

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

在澳大利亚建模和比较IVF和ICSI的使用情况

Maria Mazi¹, Georgina James², Peter Temple-Smith²

¹Education Program in Reproduction and Development, Department of Obstetrics and Gynaecology, School of Clinical Sciences at Monash Health, Monash University, Clayton, 3168, Australia. mariamazis@gmail.com.

Journal of assisted reproduction and genetics

|June 24, 2024

概括

澳大利亚澳大利亚澳大利亚

科学领域:

生殖医学生殖医学
不孕症治疗不孕症治疗
医疗保健服务研究医疗服务研究

背景情况:

试管婴儿 (IVF) 和细胞内精子注射 (ICSI) 是不孕症的关键治疗方法.
了解这些治疗的需求与采用情况对于医疗保健资源分配至关重要.
与实际使用相比,澳大利亚先前对IVF/ICSI需求的估计是有限的.

研究的目的:

估计澳大利亚每年对IVF/ICSI治疗的需求.
为了将估计的需求与实际采用IVF/ICSI程序进行比较.
根据不孕症类型,识别潜在的IVF/ICSI过量或不足的服务.

主要方法:

开发了一个数学模型来估计每年对IVF/ICSI的需求.
利用医学文献和澳大利亚政府来源的人口统计数据.
估计的需求按不孕症类型 (输卵管,男性因素,子宫内膜异位症,无排卵,不明原因) 分类,并与2019年ANZARD数据进行比较.

主要成果:

据估计,2019年在澳大利亚约有35,300对夫妇需要试管婴儿/ICSI治疗.
2019年ANZARD报告的实际吸收人数约为46,000对夫妇.
对于无法解释的不孕症,排卵障碍和子宫内膜异位症,观察到IVF/ICSI吸收率高于预期.

结论:

这项研究表明,澳大利亚的IVF/ICSI服务可能过度.
潜在的过度服务的具体领域包括无法解释的不孕不育,排卵障碍和子宫内膜异位症.
输卵管和严重的男性因子不孕症的摄入量与估计的需求相比似乎充足.

关键词:

治疗生育能力的治疗.美国国务院调查局 (ICSI)在这个过程中,IVF IVF.不孕不育不孕不育不孕不育模型人口模型人口.无法解释的不孕不育症

更多相关视频

Mouse Round Spermatid Injection

Mouse Round Spermatid Injection

Published on: January 26, 2024

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

相关概念视频

In Vitro Fertilization

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...